UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Prognostic value of site-specific metastases in pancreatic adenocarcinoma: A Surveillance Epidemiology and End Results database analysis

World journal of gastroenterology : WJG, 2017-03, Vol.23 (10), p.1872-1880

2017

Volltextzugriff (PDF)

Maturation of tertiary lymphoid structures and recurrence of stage II and III colorectal cancer

Oncoimmunology, 2018-02, Vol.7 (2), p.e1378844-e1378844

2018

Volltextzugriff (PDF)

Management von Nebenwirkungen bei bispezifischen Antikörpern und CAR-T-Zellen

InFo Hämatologie + Onkologie, 2023-04, Vol.26 (4), p.26-29

Petrausch, Ulf

2023

Volltextzugriff (PDF)

Consilium Smartphone App for Real-World Electronically Captured Patient-Reported Outcome Monitoring in Cancer Patients Undergoing anti-PD-L1-Directed Treatment

Case reports in oncology, 2020-05, Vol.13 (2), p.491-496

2020

Volltextzugriff (PDF)

Immuntherapie – Nebenwirkungen und -management

Therapeutische Umschau, 2019-09, Vol.76 (4), p.195-198

Petrausch, Ulf

2019

Volltextzugriff (PDF)

Novel sequential treatment strategy for patients with muscle-invasive bladder cancer (MIBC): intravesical recombinant BCG, followed by neoadjuvant chemoimmunotherapy, radical cystectomy plus pelvic lymphadenectomy and adjuvant immunotherapy – protocol of a multicentre, single arm phase 2 trial (SAKK 06/19)

BMJ open, 2023-06, Vol.13 (6), p.e067634

2023

Volltextzugriff (PDF)

Noninvasive rapid detection of metabolic adaptation in activated human T lymphocytes by hyperpolarized 13C magnetic resonance

Scientific reports, 2020-01, Vol.10 (1), p.200-200, Article 200

2020

Volltextzugriff (PDF)

Re-directed T cells for the treatment of fibroblast activation protein (FAP)-positive malignant pleural mesothelioma (FAPME-1)

BMC cancer, 2012-12, Vol.12 (1), p.615-615, Article 615

2012

Volltextzugriff (PDF)

Metastasiertes kastrationsresistentes Prostatakarzinom: Welche Sequenzen sind am sinnvollsten?

Urologie (Heidelberg, Germany), 2023-12, Vol.62 (12), p.1295-1301

2023

Volltextzugriff (PDF)

Are bone targeted agents still useful in times of immunotherapy? The SAKK 80/19 BTA pilot study

Bone Reports, 2024-09, Vol.22, p.101794, Article 101794

2024

Volltextzugriff (PDF)

HLA-B27-Homodimer-Specific Antibody Modulates the Expansion of Pro-Inflammatory T-Cells in HLA-B27 Transgenic Rats

PloS one, 2015-06, Vol.10 (6), p.e0130811-e0130811

2015

Volltextzugriff (PDF)

Development of PSMA-specific immunotherapy for prostate cancer with PIN4 gene-modified T cells

The Lancet (British edition), 2014-02, Vol.383, p.S77-S77

2014

Volltextzugriff (PDF)

Inhibition of meningitis-associated neutrophil apoptosis by TNF-α depends on functional PI3-kinase in monocytes

Journal of leukocyte biology, 2013-02, Vol.93 (2), p.259-266

2013

Volltextzugriff (PDF)

Phenotype and Functional Characterization of Long-term gp100-Specific Memory CD8+ T Cells in Disease-Free Melanoma Patients Before and After Boosting Immunization

Clinical cancer research, 2008-08, Vol.14 (16), p.5270-5283

2008

Volltextzugriff (PDF)

EMH-Special Onkologie / Hämatologie

Swiss medical forum, 2022-12

2022

Volltextzugriff (PDF)

Metastatic castration-resistant prostate cancer-what are rational sequential treatment options?

Urologie (Heidelberg, Germany), 2023-12, Vol.62 (12), p.1295

2023

Volltextzugriff (PDF)

Metastatic Mixed Adenoneuroendocrine Carcinoma of the Colon with Response to Immunotherapy with Pembrolizumab: A Case Report

Journal of immunotherapy (1997), 2019-09, Vol.42 (7), p.274-277

2019

Volltextzugriff (PDF)

Intravesical recombinant BCG followed by perioperative chemo-immunotherapy for patients with muscle-invasive bladder cancer (MIBC): A multicenter, single arm phase 2 trial (SAKK 06/19)

Journal of clinical oncology, 2024-02, Vol.42 (4_suppl), p.TPS707-TPS707

2024

Volltextzugriff (PDF)

Serological SARS‐CoV‐2 antibody response, potential predictive markers and safety of BNT162b2 mRNA COVID‐19 vaccine in haematological and oncological patients

British journal of haematology, 2021-11, Vol.195 (4), p.523-531

2021

Volltextzugriff (PDF)

Immune-related ocular toxicities in solid tumor patients treated with immune checkpoint inhibitors: a systematic review

Expert review of anticancer therapy, 2017-04, Vol.17 (4), p.387-394

2017

Volltextzugriff (PDF)

Efficacy and safety of heterologous booster vaccination with Ad26.COV2.S after BNT162b2 mRNA COVID‐19 vaccine in haemato‐oncological patients with no antibody response

British journal of haematology, 2022-02, Vol.196 (3), p.577-584

2022

Volltextzugriff (PDF)

Onkologie: Der Krebs auf dem Bremspedal des Immunsystems

Swiss medical forum, 2014-01, Vol.14 (3)

2014

Volltextzugriff (PDF)

Mixed response and mechanisms of resistance to larotrectinib in metastatic carcinoma ex pleomorphic adenoma of the parotid harboring an NTRK2 fusion: A case report

Medicine (Baltimore), 2021-01, Vol.100 (4), p.e24463-e24463

2021

Volltextzugriff (PDF)

Prognostic factors for survival in lymphoma patients after autologous stem cell transplantation

Swiss medical weekly, 2013-05, Vol.143, p.w13791

2013

Volltextzugriff (PDF)

Aberrant Lck Signal via CD28 Costimulation Augments Antigen-Specific Functionality and Tumor Control by Redirected T Cells with PD-1 Blockade in Humanized Mice

Clinical cancer research, 2018-08, Vol.24 (16), p.3981-3993

2018

Volltextzugriff (PDF)

1 – 25 von 82

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(71)
Mit Volltextzugriff
(59)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Prognostic value of site-specific metastases in pancreatic adenocarcinoma: A Surveillance Epidemiology and End Results database analysis

Maturation of tertiary lymphoid structures and recurrence of stage II and III colorectal cancer

Management von Nebenwirkungen bei bispezifischen Antikörpern und CAR-T-Zellen

Consilium Smartphone App for Real-World Electronically Captured Patient-Reported Outcome Monitoring in Cancer Patients Undergoing anti-PD-L1-Directed Treatment

Immuntherapie – Nebenwirkungen und -management

Noninvasive rapid detection of metabolic adaptation in activated human T lymphocytes by hyperpolarized 13C magnetic resonance

Re-directed T cells for the treatment of fibroblast activation protein (FAP)-positive malignant pleural mesothelioma (FAPME-1)

Metastasiertes kastrationsresistentes Prostatakarzinom: Welche Sequenzen sind am sinnvollsten?

Are bone targeted agents still useful in times of immunotherapy? The SAKK 80/19 BTA pilot study

HLA-B27-Homodimer-Specific Antibody Modulates the Expansion of Pro-Inflammatory T-Cells in HLA-B27 Transgenic Rats

Development of PSMA-specific immunotherapy for prostate cancer with PIN4 gene-modified T cells

Inhibition of meningitis-associated neutrophil apoptosis by TNF-α depends on functional PI3-kinase in monocytes

Phenotype and Functional Characterization of Long-term gp100-Specific Memory CD8+ T Cells in Disease-Free Melanoma Patients Before and After Boosting Immunization

EMH-Special Onkologie / Hämatologie

Metastatic castration-resistant prostate cancer-what are rational sequential treatment options?

Metastatic Mixed Adenoneuroendocrine Carcinoma of the Colon with Response to Immunotherapy with Pembrolizumab: A Case Report

Intravesical recombinant BCG followed by perioperative chemo-immunotherapy for patients with muscle-invasive bladder cancer (MIBC): A multicenter, single arm phase 2 trial (SAKK 06/19)

Serological SARS‐CoV‐2 antibody response, potential predictive markers and safety of BNT162b2 mRNA COVID‐19 vaccine in haematological and oncological patients

Immune-related ocular toxicities in solid tumor patients treated with immune checkpoint inhibitors: a systematic review

Efficacy and safety of heterologous booster vaccination with Ad26.COV2.S after BNT162b2 mRNA COVID‐19 vaccine in haemato‐oncological patients with no antibody response

Onkologie: Der Krebs auf dem Bremspedal des Immunsystems

Mixed response and mechanisms of resistance to larotrectinib in metastatic carcinoma ex pleomorphic adenoma of the parotid harboring an NTRK2 fusion: A case report

Prognostic factors for survival in lymphoma patients after autologous stem cell transplantation

Aberrant Lck Signal via CD28 Costimulation Augments Antigen-Specific Functionality and Tumor Control by Redirected T Cells with PD-1 Blockade in Humanized Mice

Suchergebnisse filtern